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The immune phenotype of the infiltrating cells in 13 
positive patch tests from 8 cases of contact dermatitis 
and 1 case of poison ivy was studied. An indirect im-
munoperoxidase technique was used in conjunction with 
monoclonal antibodies directed against mature T cells 
(Leu-1, T11), helper T cells (Leu-3A), suppressor/cyto-
toxic T cells (Leu-2A), killer and natural killer cells 
(HNK 1), B cells (B1), Langerhans cells (HLA-DR), and 
the common acute lymphoblastic leukemia antigen 
(CALLA), (Jr;). The majority of infiltrating mononuclear 
cells were Leu-1+, T11+, Leu-3A+, Leu-2A-, HLA-DR+, 
T9-, T 1 o-, HNK-, B 1-, J 5 - . Occasional T6+ cells were 
observed in the epidermis (including spongiotic micro-
vesicles) and also isolated in the dermis and within the 
dermal mononuclear infiltrates. The phenotype was 
compared with cutaneous T-cell lymphoma, a disease in 
which contact allergy and antigenic persistence may 
play a role. 
The recent advent of monoclonal antibod ies directed to T 
cells, and T-cell subsets [1] has permitted the analysis of the 
immune phenotype of the lymphoid populations in normal [2-
4] and pathologic tissue [5]. A larger amount of effort concen-
trated on cutaneous T-cell lymphoma (CTCL) has shown the 
infiltrating cells to have a phenotype similar to t hat of mature 
helper T cells [6-11]. Cells bearing so-called immature differ-
entiation antigens have also been identified in cutaneous lym-
phoma intiltrates. There has been comparatively little work 
done on the nature of the infil t rating cells in benign dermatoses 
a lthough one study has reported the phenotype of cells in 
another form of cell -mediated immunity, the t uberculin skin 
reaction [12]. Despite a large amount of work done on experi-
mental aspects of contact dermatitis in animals [13), compar-
atively little has been done on human cases of contact derma-
titis. 
We therefore decided to study the immune phenotype of 
human allergic contact dermatitis using monoclonal antibodies 
directed against mature T cells [14], T -cell subsets [14], im-
mature differentiation antigens [ 15], killer (K) and natural 
killer (NK) cells [16], B cells [17], Langerhans cells [18-20], 
and an antigen expressed on lymphoblastic leukemia cells 
[21] . 
MATERIALS AND METHODS 
Thirteen positive patch tests from 8 patients with allergic contact 
dermatitis and 1 lesional biopsy of poison ivy were studied. The 
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Abbreviations: 
ALL: acute lymphoblastic leukemia 
CALLA: common acute lymphoblastic leukemia antigen 
CTCL: cutaneous T-celllymphoma 
K: killer (cell} 
NK: natural killer (cell} 
PPO: paraphenylene diamine 
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"posit ively reacting" substances were rosin, paraphenylene diamine 
(PPD} mix, isopropyl- n-phenyl paraphenylene diamine (IPPD}, fra-
grance, Furasizone, Mercapto mix, ammoniated mercury, Merthiolate 
(2 cases}, chromate, nickel (2 cases}, and neomycin. Patch tests were 
read at 48 h. 
Immunophenotyping was carried out on cryostat sections as de-
scribed previously [ 4, 7]. Sections counterstained with hematoxylin were 
also examined in order to estimate the number of ce lls staining posi-
tively with each antibody and to more clearly delineate the microenvi-
ronment of the positively staining cells. 
Positive controls consisted of human tonsil and a case of CTCL. 
The only exception to t his was with the J, monoclonal antibody which 
detects the common acute lymphoblastic leukemia antigen (CALLA} 
[21]. This antibody was, however, used in a concentration in excess of 
that which detects CALLA in other tissues [21] . 
The monoclonal antibodies used, their source and specificities a re 
shown in Table I. 
RESULTS 
In the cases examined, >50% of the infiltrating cells in 
dermis and epidermis reacted with Leu-1 (Pan T) (Figs 1-4) 
and Til (E receptor). The majority of t hese cells were Leu-
3A + (helper), the helper/suppressor ratio varying from 2:1 to 
10:1, larger numbers of helper cells being observed in denser 
infiltrates. The HLA-DR antibody (Figs 5-9) tended to produce 
a level of staining above background level throughout the 
ep idermis, suggesting expression of HLA-DR by keratinocytes. 
The distribution of this effect tends to be uneven. A more 
intense level of positive staining with HLA-DR was also noted 
in (1) isolated epidermal dendritic cells; (2) cells surrounding 
and wit hin spongiotic microvesicles; these consisted of rounded 
and dendritic forms; (3) dermal cells; isolated HLA-DR+ den-
TABLE I. Monoclonal antibodies used to phenotype infiltrating celL~ in 
allergic contact dermatitis 
Monoclonal Antibody 
Leu-1 " 
Leu -3A" 
Leu-2A" 
Tu• 
B1• 
HLA -DR" 
T 6' 
T9' 
T10' 
HNKl (Leu-7}" 
J ,, (CALLA)• 
Speci fi city 
PanT (mature) [14] 
Helper T [14] 
Cytotoxic/Suppressor T [ 14] 
PanT (E receptor} [22] 
B cells, B cell lymphomas [17] 
B cells, monocytes, macrophages 
Langerhans cells, activated T 
cells [11] 
Common thymocytes [2,23,24] 
Langerhans cells {10,18,19] 
Immature T, T cell ALL, CTCL, 
activated T [23 ] wide range of 
proliferating cell types, e.g. ce ll 
lines of mammary carinoma 
Immature T , bone marrow pro-
geni tor cells [23], some killer 
cell [25], some activated T cells 
[23] 
K and NK cells [16] 
Common acute lymphoblastic 
leukemia ant igen [21] 
" Becton Dickinson Facs Systems, Sunnyvale, Californ ia. 
• Coulter Electronics, Bethesda, Maryland. 
' Orthoimmunobiology, Ltd. , Raritan, New Jersey. 
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FIG 1. Leu+ cells in dermis. Indirect immunoperoxidase. Non coun-
terstained. Bar = 33 llm. 
FIG 2. Leu-1+ exocytic cells in epidermis (E) and underlying dermis 
(D). Indirect immunoperoxidase. Non counterstained. Bar= 33 /Lm . 
dritic cells were observed throughout dermis (especially in the 
papillary and superficial reticular dermis). HLA-DR+ dendritic 
cells were also interspersed throughout the perivascular mono-
nuclear cell infiltrates. HLA-DR positivity with a confluent 
pattern was also observed throughout the perivascular mono-
nuclear cell infiltrates indicating that the majority of the Leu-
1 + and Tn+ cells were also HLA-DR+ (although the density of 
ant igenic staining was less than in the HLA-DR+ dendritic 
cells) . The confluent HLA-DR positivity of perivascular cells 
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tended to vary in intensity both within the same specimen and 
among different biopsy specimens. The T6 antibody reacted 
with epidermal dendritic cells, cells within microvesicles (Fig 
10), and dendritic cells lying free and interspersed throughout 
the dermal mononuclear infiltrates. The T6+ dendritic cells 
accounted for 5-10% of the infiltrating dermal cells. Only 
occasional cells ( <1 %) reacted with HNK 1 (K and NK) and 
B1 (B cell) antibodies. A negative reaction was obtained with 
T9 (immature) and TlO (immature) and J5 (CALLA) antibod-
ies. 
Positive controls were positive and all negative controls were 
negative. 
-FIG 3. Leu-1 +cell (arrow) at edge of spongiotic microvesicles. Arrow 
indicates peroxidase positive product on lymphocyte reacting with 
monoclonal antibody Leu-1. Epidermis (E) . Indirect immunoperoxi-
dase. Non counterstained. Bar = 21/Lm. 
E 
t s 
-FIG 4. Leu-1+ cells in spongiotic microvesicle (S). Closed arrows 
point to peroxidase positive product on Leu 1 + T cells. Negatively 
staining dendritic cells show faint uptake of background stain (open 
arrows). Open arrows point to barely visible background on Leu-1-
dendritic histiocytes. E = epidermis. Dendritic cells staining positively 
with other monoclonal antibodies are shown in later figures. Indirect 
immunoperoxidase. Non counterstained. Bar= 21/Lm. 
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FIG 5. HLA-DR+ cells in epidermis (E) and dermis (D). Dendritic 
forms are arrowed. Indirect immunoperoxidase. Non counterstained. 
Bar= 21JLm. 
.~ · -~ 
·s 
FIG 6. HLA-DR+ cells in 3 adjacent spongiotic microvesicles (S) . 
Numerous HLA-DR+ cells lie within the vesicles. Positively staining 
cells appear to be present in increased concentrations at the edge of 
the vesicles, and in one area appear intensely grouped (arrow). Indirect 
irnmunoperoxidase. Non counterstained. Bar= 83 JLm. 
DISCUSSION 
This study showed the majority of infiltrating lymphocytes 
in allergic contact dermatitis to have a Tll , Leu-1, Leu-3A 
positive phenotype. As far as mature T-cell markers are con-
cerned, the phenotype was similar to that of CTCL. The results 
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FIG 7. HLA-DR+ cells in dermis. Numerous dendritic forms are 
present in papillary (P) and upper reticular dermis (R). E =epidermis. 
Indirect immunoperoxidase. Non counterstained. Bar = 33 JLID. 
E 
FIG 8. Dense accumulation of HLA-DR+ epidermal cells at edge of 
spongiotic microvesicle (S) . E = epidermis. Indirect immunoperoxi-
dase. Non counterstained. Bar= 21 JLffi. 
suggest that the effector cells in allergic contact dermatitis have 
the phenotype of mature T helper cells. This is compatibte with 
one recent study of cell-mediated immunity (PPD intradermal 
skin testing) where the infiltrating cells were shown to have an 
OKT3+, OKT4+ (helper) phenotype [12]. The infiltrating cells 
in various forms of inflammatory myopathy have also recently 
been shown to have a similar Leu-1+, Leu-3A+ phenotype 
[26]. The demonstration of a Leu-1 +, Leu-3A + phenotype in 
the infiltrating cells of irritant contact reactions [27] suggests 
that Leu-3A positivity probably cannot be used to differentiate 
the allergic from the irritant model. 
The staining pattern obtained with HLA-DR antibody in 
epidermis is compatible with the presence of HLA-DR antigen 
on Langerhans cells and epidermal cells [28]. It is uncertain 
how many of the rounded HLA-DR+ cells within spongiotic 
microvesicles were Langerhans cells rounded by antigenic stim-
ulation or activated T cells. The confluent staining pattern 
produced by HLA-DR on the infiltrating dermal T-cell popu-
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FIG 9. Dense accumulation of HLA-DR+ cells at edge of and be-
tween 2 adjacent spongiotic microvesicles (S). Indirect immunoperox-
idase. Non counterstained. Bar = 21 I'm. 
E s 
-FIG 10. T 6+ cells adjacent to and within spongiotic microvesicle (S) 
in epidermis (E). Open arrows point to peroxidase-positive product on 
histiocytic cells reacting with monoclonal antibody T6. The T6+ cells 
within the microvesicle tend to have a more rounded morphology than 
usually seen with the T6 antibody in epidermis. Indirect immuno-
peroxidase. Non counterstained. Bar= 21 I'm· 
lation suggests that many of the cells had the phenotype of 
activated T cells [29]. Some of the dermal HLA-DR reactivity 
was undoubtedly contributed by Langerhans cells (see below). 
The preponderantly negative reactions with monoclonal anti-
body B1 indicates that HLA-DR positivity was not mainly due 
to B cells. 
T6+ dendritic cells were noted throughout the epidermis 
including spongiotic microvesicles. They were also noted ap-
parently lying free within the dermis and throughout the dermal 
mononuclear infiltrates (which consisted preponderantly of 
mature Leu-1 +, Tll + T cells). The pattern of T6 reactivity 
indicates that HLA-DR reactivity observed was not due solely 
to positively staining Langerhans cells, substantiating that 
HLA-DR reactivity also resided on the T-cell population. Al-
though studies of this kind do not give direct information on 
cell function, the close approximation of T6+ cells to T cells 
provides evidence that Langerhans cells may play an important 
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role in contact dermatitis in humans. There is certainly good 
animal evidence that these cells function in the handling and 
presentation of antigen to T cells [30-32], and lymphocytes 
have been noted in close apposition to Langerhans cells in 
contact dermatitis in animals [32,33]. The role of antigen-
presenting cells in delayed-type hypersensitivity has recently 
been reviewed [33]. The T6+ dermal cells may account in part 
for the T3- histiocytes found adjacent to lymphocytes in con-
tact allergic reactions [34). 
The reaction obtained with monoclonal antibody B1 is con-
sistent with current concepts of the relative importance of B 
cells in humoral immunity and T cells in cell -mediated immu-
nity [35,36). 
Only rare cells in epidermis and dermis were noted to react 
with the monoclonal antibody HNK 1 and only in one case. K 
and NK cells are believed to have an important function in 
immunity of animals against tumors and viruses [25] . Their 
importance in humans is, at present, less clear [25] . Several 
types of cells are involved in cellular cytotoxicity [25]. Our 
study indicates that the damage in contact dermatitis is prob-
ably mediated via classical T lymphocytes rather than K or 
NK cells, which apparently have properties of both monocytes 
(OKM1 +) and T cells (weak E rosette positivity) [25]. These 
results are also compatible with animal evidence that contact 
sensitivity and cellular cytotoxicity are mediated by different 
lymphocyte subclasses [37,38] as only occasional cells produced 
a positive reaction with Leu-2A. It must be emphasized that 
reactions were studied only at 48 h and that sequential testing 
may reveal variation in the distribution and quantity of various 
subpopulations. For instance, cells with a suppressor phenotype 
may be more common in later stages of developing or resolving 
(spontaneous or iatrogenic) lesions. 
The negative reaction obtained with T9 and TlO was of great 
interest. Both these antigens may be expressed by a proportion 
of the infiltrating cells in CTCL [39-41] . This may be due to 
immaturity or "dedifferentiation" from neoplastic transforma-
tion. Since both the T9 and T10 determinants may be expressed 
by a proportion ofT cells undergoing antigen-induced activa-
tion in vitro [23], we expected to find a positive reaction in 
contact dermatitis with these antibodies. Several explanations 
are possible for this unexpectedly negative reaction. It is pos-. 
sible that antigen-induced transformation in vivo differs from 
the neoplastic transformation of CTCL. This may be a quan-
titative difference rather than an absolute difference in expres-
sion of the T9 and T10 antigens. The negative results obtained 
here may, in part, reflect the sensitivity of the technique used, 
and possibly a more sensitive technique such as the avidin-
biotin method would produce T9 and T10 positivity. Most of 
the blastic transformation ofT lymphocytes in contact sensi-
tivity appears to occur in the local draining lymph node [ 42) 
and so it is possible that T9 and TlO reactivity might be more 
prevalent in lymph nodes draining affected areas. It is of course 
also possible that T9+ and TlO+ cells may be more prevalent 
at other stages in the contact reaction. Despite these anatomic 
and technical considerations, our results do suggest that "im-
mature" markers may be preferentially expressed in lympho-
mas. The result obtained with OKT6 is also of interest in the 
context of CTCL where a T6+ dendritic subpopulation has been 
noted [7- 10) throughout the helper T-cell infiltrates. Contact 
allergens [43,44] and antigen persistence [45] have been impli-
cated in the pathogenesis of CTCL. The similarity of pheno-
types noted here, namely Leu 1+, Tll+, Leu-3A+ with inter-
spersed T6+ cells is consistent with this hypothesis and a 
similar phenotype has been shown in prelymphomatous states 
[20,46). However, the difference in OKT9 and OKTlO reactiv-
ity observed in skin between CTCL and one phase of contact 
dermatitis suggests that further comparisons should be per-
formed between benign and malignant states. 
The negative reaction with J s which detects CALLA provides 
additional data on the spectrum of reactivity of this marker. 
CALLA is presently known to be expressed on acute lympho-
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blastic leukemia (ALL) cells, some lymphomas, and some non-
malignant tissues [21]. 
In summary, ou r results have shown the preponderant phe-
notype of the infil trati ng cells in contact dermatitis to be that 
of mature helper T cells (Leu-1 +, Tll +, Leu-3A +) with an 
admixture of infiltrating T6+ cells (Langerhans). This pheno-
type is similar to that observed in CTCL, but an empirical 
difference in reactivity with the immature markers OKT9 and 
OKTlO has been observed between acute allergic contact der-
matitis and CTCL. These findings suggest that further studies 
comparing the thymic diffe rentiation status of benign and 
malignant lymphoid cells would be worthwhile. 
I wish to thank Patty Estep for her assistance m the clerical 
preparation of th is manuscript. 
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